![Kurt Schmidt](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Network origin in Kurt Schmidt first degree
Entity | Entity type | Industry | |
---|---|---|---|
Public Company | Medical Specialties | 8 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Kurt Schmidt via their personal network
Company | Sector | Related people | Main position |
---|---|---|---|
Katholieke Universiteit Leuven | College/University | Graduate Degree Doctorate Degree | |
BIOCARTIS GROUP NV | Medical Specialties | Chief Executive Officer Director of Finance/CFO | |
Quest Diagnostics Infectious Disease, Inc.
![]() Quest Diagnostics Infectious Disease, Inc. Miscellaneous Commercial ServicesCommercial Services Quest Diagnostics Infectious Disease, Inc. provides diagnostic services. It offers anti infective surveillance and consultative services to the diagnosis, treatment, and management of infectious diseases. The company was founded in 1978 and is headquartered in Cypress, CA. | Miscellaneous Commercial Services | Chief Tech/Sci/R&D Officer Director of Finance/CFO | |
MyCartis NV
![]() MyCartis NV BiotechnologyHealth Technology MyCartis NV develops technologies for healthcare personalization needs. It offers Evalution, a multiplex analysis platform to develop protein and nucleic-acid based clinical biomarkers. The company provides disruptive solutions in the fields of clinical and translational research for various applications in the detection of proteins and nucleic acids, such as sandwich immunoassays, antibody assays, genotyping assays, and mutation analysis assays to customers and partners. It offers products for various disease areas, including cell signalling, cardiovascular, oncology, and preeclampsia. The company was founded by Koen Kas in August 2004 and is headquartered in Ghent, Belgium. | Biotechnology | Chief Executive Officer Director/Board Member | |
Ghent University | College/University | Graduate Degree Graduate Degree | |
DXOrange BV | Founder | ||
Destina Genomics Ltd.
![]() Destina Genomics Ltd. BiotechnologyHealth Technology Destina Genomics Ltd. is engaged in development of molecular diagnostic products. Its products include pipeline assay kits and liverace. The company was founded by Hugh Llyine, Juan J. Diaz-Mochon and Mark Bradley in 2011 and is headquartered in Edinburgh, the United Kingdom. | Biotechnology | Director/Board Member | |
Novigenix SA
![]() Novigenix SA Medical SpecialtiesHealth Technology Novigenix SA develops molecular diagnostics for cancer. The firm specializes in new generation liquid biopsy tests for early detection of cancer and precision medicine. The company was founded by Sahar Hosseinian in 2014 and is headquartered in Epalinges, Switzerland. | Medical Specialties | Director/Board Member | |
ANGLE PLC | Medical Distributors | Chairman | |
IBL International BV | Director/Board Member | ||
AKZO NOBEL N.V. | Industrial Specialties | Corporate Officer/Principal | |
Cergentis BV
![]() Cergentis BV Miscellaneous Commercial ServicesCommercial Services Part of Solvias AG, Cergentis BV is a Dutch genomics company that develops and commercializes TLA-based diagnostic kits for targeted complete next-generation sequencing of (trans) genes and gene editing events. The company is based in Utrecht, Netherlands. The company also provides commercial services for leading research institutes and pharmaceutical companies worldwide. The company was founded in 2012. Joris Schuurmans has been the CEO of the company since 2020. Cergentis was acquired by Solvias AG on July 12, 2022. | Miscellaneous Commercial Services | Chairman | |
Erasmus MC
![]() Erasmus MC Hospital/Nursing ManagementHealth Services Erasmus MC operates as an academic hospital. It is affiliated with the Erasmus University of Rotterdam, and home to its faculty of medicine. It has special units such as Neurosurgery, Cardiograph surgery, Neonatal and pediatric surgery and intensive care, Pediatric oncology and Level I trauma center. The company was founded in 2002 and is headquartered in Rotterdam, Netherlands. | Hospital/Nursing Management | Corporate Officer/Principal | |
ViroClinics Biosciences BV
![]() ViroClinics Biosciences BV Pharmaceuticals: MajorHealth Technology ViroClinics Biosciences BV engages in the provision of diagnostic and clinical trial solutions. It offers research and development, preclinical, clinical trial operation, diagnostic testing, virus discovery, and quality assurance services. The company was founded by Albert Osterhaus in 2001 and is headquartered in Rotterdam, the Netherlands. | Pharmaceuticals: Major | Founder | |
Agendia, Inc.
![]() Agendia, Inc. Pharmaceuticals: MajorHealth Technology Agendia, Inc. operates as a molecular diagnostics company. It develops and markets FFPE-based genomic diagnostic products, which help support physicians with their treatment decisions. Agendia?s tests can help physicians assess a patient?s individual risk for metastasis, it benefits from chemo, hormonal or combination therapy. The company was founded by Laura van't Veer and Ren? Bernards in 2003 and is headquartered in Irvine, CA. | Pharmaceuticals: Major | President | |
Agendia NV
![]() Agendia NV Medical/Nursing ServicesHealth Services Agendia NV discovers and develops products for clinical management of cancer. It operates as a commercial-stage molecular diagnostic company that focuses on the discovery, development, and commercialization of products to improve the quality of life for cancer patients. The company was founded by Rene Bernards and Laura van't Veer in 2003 and is headquartered in Amsterdam, the Netherlands. | Medical/Nursing Services | Chief Operating Officer | |
Erasmus University Rotterdam | College/University | Doctorate Degree | |
Saving Patients' Lives Medical BV
![]() Saving Patients' Lives Medical BV Medical SpecialtiesHealth Technology Saving Patients' Lives Medical BV develops and manufactures nano-sized iron oxide particles for effective diagnostics of cancer metastasis. The company was founded by Ari Aminetzah and Patrik Zamecnik in 2015 and is headquartered in Nijmegen, the Netherlands. | Medical Specialties | Director/Board Member | |
Intravacc BV
![]() Intravacc BV BiotechnologyHealth Technology Institute for Translational Vaccinology is a Dutch independent company that partners with clients in vaccine development, from discovery to pilot production to clinical studies. The non-profit company is based in Bilthoven, Netherlands. Intravacc designs and creates the best candidate organisms for vaccine strain, looking for the highest immunity, potency, and production yield. The company substantially reduces the risks and costs involved with developing vaccines by bridging the gap between concept and late-stage clinical studies. Intravacc's upstream processing expertise covers both bacterial and cell cultivation as well as virus propagation in reactors ranging from 1l up to 200l. The company's scientists design, develop, and improve vaccine formulations that are suitable for the intended administration route and stable upon storage. | Biotechnology | Chief Executive Officer | |
Bristol-Myers Squibb Belgium SA
![]() Bristol-Myers Squibb Belgium SA Pharmaceuticals: MajorHealth Technology Part of Bristol Myers Squibb Co., Bristol-Myers Squibb Belgium SA develops, manufactures and distributes medicines. The company is based in Watermael-Boitsfor, Belgium. The CEO of the Belgian company is Paul Lacante. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Stichting Tegen Kanker | Investment Trusts/Mutual Funds | Director/Board Member | |
Qaly-Co BV | Founder | ||
MERCK & CO., INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Imelda Hospital | Director/Board Member | ||
Euronext Brussels SA/NV
![]() Euronext Brussels SA/NV Investment Banks/BrokersFinance Euronext Brussels SA/NV operates a stock exchange. It provides services for regulated stock and derivatives markets in Belgium. The company also offers services, such as facilitating public offerings, providing trading facilities for cash & derivatives products and supplying market data. Euronext Brussels was founded in 1801 and is headquartered in Brussels, Belgium. | Investment Banks/Brokers | Director/Board Member | |
QUEST FOR GROWTH NV | Investment Managers | Director/Board Member | |
Qaly | Chief Executive Officer | ||
OxDX Ltd.
![]() OxDX Ltd. Packaged SoftwareTechnology Services OxDX Ltd. builds instant pathogen test detection using resolution microscopy and machine learning. The company is based in Headington, UK. The British company was founded by Alex Batchelor, Nicolas Shiaelis, and Nicole Robb. Alex Batchelor has been the CEO since incorporation. | Packaged Software | Chairman | |
University of Antwerp | College/University | Graduate Degree | |
MATERIALISE NV | Packaged Software | Director/Board Member | |
Captek Holdings, Inc.
![]() Captek Holdings, Inc. Pharmaceuticals: OtherHealth Technology Captek Holdings, Inc. operates as a holding company. The company is based in Cerritos, CA and has subsidiaries in United States. | Pharmaceuticals: Other | Director of Finance/CFO | |
The Leeds School of Business | College/University | Undergraduate Degree | |
Haas School of Business | College/University | Masters Business Admin | |
Vlerick Leuven Gent Management School | College/University | Masters Business Admin | |
Ernst & Young Belgium
![]() Ernst & Young Belgium Miscellaneous Commercial ServicesCommercial Services Ernst & Young Belgium provides accounting services. Its services include assurance, tax, advisory, transactions and strategic growth. The company is headquartered in Machelen, Belgium. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
PHAXIAM THERAPEUTICS S.A. | Pharmaceuticals: Major | Director/Board Member | |
MYRIAD GENETICS, INC. | Medical Specialties | Chief Tech/Sci/R&D Officer | |
Northwest Prostate Institute | Director/Board Member | ||
deVGen NV
![]() deVGen NV BiotechnologyHealth Technology deVGen NV provides biotechnology services for the pharmaceutical and agrochemical industries. It innovates in crop protection research and environment induced stress tolerance for its own crops and provides technology to corporate partners. The firm produces and sells its hybrid seeds in field crops such as rice, sunflower, sorghum and pearl millet in the Indian subcontinent and Southeast Asia. The company was founded by Thierry Bogaert on September 10, 1997 and is headquartered in Ghent, Belgium. | Biotechnology | Director of Finance/CFO | |
SEPS Pharma NV
![]() SEPS Pharma NV Pharmaceuticals: GenericHealth Technology SEPS Pharma NV provides controlled drug delivery and develops self emulsifying pro drug systems. Its services include preformulation, formulation development and analytical development. The company was founded on October 19, 2007 and is headquartered in Diepenbeek, Belgium. | Pharmaceuticals: Generic | Director of Finance/CFO | |
ING Bank NV, Amsterdam, succursale de Lancy/Genève
![]() ING Bank NV, Amsterdam, succursale de Lancy/Genève Regional BanksFinance ING Bank NV, Amsterdam, succursale de Lancy/Genève provides commercial banking services. Its banking products include saving and current accounts, credit cards, loans and investments. The firm offers vehicle insurance, home insurance, life insurance and retirement plans. The company was founded in 1871 and is headquartered in Brussels, Belgium. | Regional Banks | Corporate Officer/Principal | |
Biocartis SA
![]() Biocartis SA Medical SpecialtiesHealth Technology Biocartis SA develops molecular diagnostic solutions. It focuses on Oncology. The firm’s products include Idylla and Oncology assays and mutation tests. It also provides instant access to personalized medicine for patients. The company was founded by Rudi Pauwels in 2007 and is headquartered in Lausanne, Switzerland. | Medical Specialties | Chief Executive Officer | |
FlandersBio vzw
![]() FlandersBio vzw Miscellaneous Commercial ServicesCommercial Services FlandersBio vzw is a life sciences cluster organization based in Flanders, Belgium. FlandersBio creates value by organizing networking and training activities, supporting internationalization, providing services, and building expertise. The Belgian company was founded by Jean Marie Stassen. | Miscellaneous Commercial Services | Director/Board Member | |
Vlaams Instituut voor Biotechnologie - Flanders Institute
![]() Vlaams Instituut voor Biotechnologie - Flanders Institute Other Consumer ServicesConsumer Services Vlaams Instituut voor Biotechnologie - Flanders Institute operates as a non-profit organization, provides research and development services. It specializes in translating basic scientific results into pharmaceutical, agricultural and industrial applications. The company was founded on January 1, 1996 and is headquartered in Ghent, Belgium. | College/University | Director/Board Member | |
ABLYNX | Biotechnology | Director/Board Member |
Statistics
International
Belgium | 22 |
Netherlands | 11 |
United States | 10 |
United Kingdom | 5 |
Switzerland | 4 |
Sectoral
Health Technology | 20 |
Consumer Services | 9 |
Commercial Services | 5 |
Finance | 5 |
Technology Services | 4 |
Operational
Director/Board Member | 38 |
Independent Dir/Board Member | 14 |
Director of Finance/CFO | 13 |
Chief Executive Officer | 12 |
Chairman | 11 |
Most connected contacts
Insiders | |
---|---|
Jan Groen | 19 |
Hilde Windels | 18 |
Godelieve Verplancke | 13 |
Koen Hoffman | 11 |
Michael K. McGarrity | 7 |
Jean-Marc Roelandt | 7 |
Michael K. Brawer | 5 |
Francis Ota | 5 |
- Stock Market
- Insiders
- Kurt Schmidt
- Company connections